Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|10|1818-1826

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.10, 2013-03, pp. : 1818-1826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 10, 2016-04 ,pp. : 1074-1090

Bentham Science Publishers

Access to resources Recommend Favorite

HIV Entry Inhibitors Targeting gp41: From Polypeptides to Small-Molecule Compounds

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 143-162

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-Aided Design, Synthesis, and Biological Activity Evaluation of Potent Fusion Inhibitors Targeting HIV-1 gp41

By  

Medicinal Chemistry, Vol. 7, Iss. 4, 2011-07 ,pp. : 309-316

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesized Peptide Inhibitors of HIV-1 gp41-dependent Membrane Fusion

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1800-1809

Bentham Science Publishers

Access to resources Recommend Favorite

Amphipathic Properties of HIV-1 gp41 Fusion Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 24, 2011-12 ,pp. : 3022-3032

Bentham Science Publishers

Access to resources Recommend Favorite